首页 > 最新文献

Journal of hospital medicine最新文献

英文 中文
Mortality after broad- versus narrow-spectrum antibiotic treatment for patients with nursing and healthcare-associated pneumonia: A nationwide retrospective cohort study. 护理和保健相关肺炎患者广谱与窄谱抗生素治疗后的死亡率:一项全国回顾性队列研究。
IF 2.3 Pub Date : 2025-10-08 DOI: 10.1002/jhm.70195
Jumpei Taniguchi, Shotaro Aso, Hiroki Matsui, Kiyohide Fushimi, Hideo Yasunaga

Background: Nursing and healthcare-associated pneumonia (NHCAP) is defined as pneumonia occurring in individuals with frequent healthcare contact, such as residents of care facilities or patients with impaired activities of daily living. The effectiveness of broad-spectrum antibiotics in treating NHCAP remains unclear.

Objective: To compare clinical outcomes between broad- and narrow-spectrum antibiotic treatments in patients with NHCAP using a nationwide inpatient database.

Methods: Patients diagnosed with NHCAP between April 2014 and March 2022 were identified from the Diagnosis Procedure Combination inpatient database in Japan. Patients were categorised into those receiving broad-spectrum antibiotics (antipseudomonal penicillins, antipseudomonal cephalosporins, and carbapenems) and those receiving narrow-spectrum antibiotics (third-generation cephalosporins and penicillin plus β-lactamase inhibitor combinations). Instrumental variable analysis using hospital preference for broad-spectrum antibiotics was conducted to compare 30-day in-hospital mortality. A subgroup analysis was performed for patients with ≥3 risk factors for antibiotic-resistant pathogens.

Results: Among 828,283 eligible patients, 24.8% received broad-spectrum antibiotics, while 75.2% received narrow-spectrum antibiotics. Instrumental variable analysis showed that broad-spectrum antibiotic use was not associated with 30-day in-hospital mortality (10.0% vs. 10.0%; risk difference, 0.0%; 95% confidence interval, -0.7% to 0.8%) compared with narrow-spectrum antibiotic use. The subgroup analysis of patients with three or more risk factors for antibiotic-resistant pathogens, broad-spectrum antibiotic use was also not associated with 30-day mortality (10.5% vs. 11.0%; risk difference, -0.6%; 95% confidence interval, -2.5% to 1.3%).

Conclusions: Broad-spectrum antibiotic use was not associated with short-term in-hospital mortality in patients with NHCAP, underscoring the importance of individualized antibiotic selection based on patient-specific risk factors.

背景:护理和卫生保健相关肺炎(NHCAP)被定义为发生在经常接触卫生保健的个体中的肺炎,如护理机构的居民或日常生活活动受损的患者。广谱抗生素治疗NHCAP的有效性尚不清楚。目的:利用全国住院患者数据库比较广谱和窄谱抗生素治疗NHCAP患者的临床结果。方法:从2014年4月至2022年3月日本诊断程序组合住院患者数据库中筛选诊断为NHCAP的患者。患者被分为接受广谱抗生素(抗假单胞菌青霉素、抗假单胞菌头孢菌素和碳青霉烯类)和接受窄谱抗生素(第三代头孢菌素和青霉素加β-内酰胺酶抑制剂联合)的患者。利用医院对广谱抗生素的偏好进行工具变量分析,比较30天住院死亡率。对具有≥3种耐药病原菌危险因素的患者进行亚组分析。结果:828,283例符合条件的患者中,使用广谱抗生素的占24.8%,使用窄谱抗生素的占75.2%。工具变量分析显示,与窄谱抗生素使用相比,广谱抗生素使用与30天住院死亡率无关(10.0% vs 10.0%;风险差为0.0%;95%置信区间为-0.7% ~ 0.8%)。对具有三个或更多耐药病原体危险因素的患者进行亚组分析,广谱抗生素的使用也与30天死亡率无关(10.5% vs 11.0%;风险差异-0.6%;95%置信区间-2.5%至1.3%)。结论:广谱抗生素的使用与NHCAP患者的短期住院死亡率无关,强调了基于患者特异性危险因素个性化抗生素选择的重要性。
{"title":"Mortality after broad- versus narrow-spectrum antibiotic treatment for patients with nursing and healthcare-associated pneumonia: A nationwide retrospective cohort study.","authors":"Jumpei Taniguchi, Shotaro Aso, Hiroki Matsui, Kiyohide Fushimi, Hideo Yasunaga","doi":"10.1002/jhm.70195","DOIUrl":"https://doi.org/10.1002/jhm.70195","url":null,"abstract":"<p><strong>Background: </strong>Nursing and healthcare-associated pneumonia (NHCAP) is defined as pneumonia occurring in individuals with frequent healthcare contact, such as residents of care facilities or patients with impaired activities of daily living. The effectiveness of broad-spectrum antibiotics in treating NHCAP remains unclear.</p><p><strong>Objective: </strong>To compare clinical outcomes between broad- and narrow-spectrum antibiotic treatments in patients with NHCAP using a nationwide inpatient database.</p><p><strong>Methods: </strong>Patients diagnosed with NHCAP between April 2014 and March 2022 were identified from the Diagnosis Procedure Combination inpatient database in Japan. Patients were categorised into those receiving broad-spectrum antibiotics (antipseudomonal penicillins, antipseudomonal cephalosporins, and carbapenems) and those receiving narrow-spectrum antibiotics (third-generation cephalosporins and penicillin plus β-lactamase inhibitor combinations). Instrumental variable analysis using hospital preference for broad-spectrum antibiotics was conducted to compare 30-day in-hospital mortality. A subgroup analysis was performed for patients with ≥3 risk factors for antibiotic-resistant pathogens.</p><p><strong>Results: </strong>Among 828,283 eligible patients, 24.8% received broad-spectrum antibiotics, while 75.2% received narrow-spectrum antibiotics. Instrumental variable analysis showed that broad-spectrum antibiotic use was not associated with 30-day in-hospital mortality (10.0% vs. 10.0%; risk difference, 0.0%; 95% confidence interval, -0.7% to 0.8%) compared with narrow-spectrum antibiotic use. The subgroup analysis of patients with three or more risk factors for antibiotic-resistant pathogens, broad-spectrum antibiotic use was also not associated with 30-day mortality (10.5% vs. 11.0%; risk difference, -0.6%; 95% confidence interval, -2.5% to 1.3%).</p><p><strong>Conclusions: </strong>Broad-spectrum antibiotic use was not associated with short-term in-hospital mortality in patients with NHCAP, underscoring the importance of individualized antibiotic selection based on patient-specific risk factors.</p>","PeriodicalId":94084,"journal":{"name":"Journal of hospital medicine","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2025-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145254336","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Variation in initiation of medications for alcohol use disorder during alcohol withdrawal hospitalizations in a large health system: A retrospective cohort study. 在一个大型卫生系统中,酒精戒断住院期间酒精使用障碍药物的起始变化:一项回顾性队列研究。
IF 2.3 Pub Date : 2025-10-08 DOI: 10.1002/jhm.70201
Eden Y Bernstein, Jacob A Lebin, Jason Hoppe, Izzie Clinton, R Mark Gritz, Gina R Kruse, E Jennifer Edelman

Background: Alcohol withdrawal hospitalizations present unmet opportunities to initiate medications for alcohol use disorder (MAUD).

Objective: To examine patient and hospital factors associated with MAUD initiation during hospitalizations.

Methods: We conducted a retrospective cohort study of alcohol withdrawal hospitalizations in a large health system using electronic health record and pharmacy data from 2022 to 2024. The outcome was MAUD initiation defined as inpatient administration of injectable naltrexone or prescriptions for outpatient oral naltrexone, acamprosate, disulfiram, topiramate, or baclofen. We excluded patients who filled MAUD in the prior 90 days. We used a multivariable linear model with socioeconomic, clinical, and hospitalization factors as fixed effects and individual patients and hospital sites as random effects to account for clustering.

Results: Among 5993 alcohol withdrawal hospitalizations across 12 hospitals, 19.8% (range: 5.1%- 43.2%) initiated MAUD. Oral naltrexone was the most common MAUD initiated, while topiramate was the least common (66.9% and 1.2% of MAUD initiated, respectively). Patients less likely to initiate MAUD were age ≥ 65 years (absolute adjusted difference -6.89 percentage points [pp] vs. age 18-29; 95% confidence interval [CI] -12.20, -1.58) and those without cirrhosis and liver enzymes >200 U/L (-3.46 pp vs. liver enzymes ≤ 200 U/L; 95% CI: -6.87, -0.01). Four hospitals initiated MAUD at significantly lower rates, and two at higher rates including the only hospital with an addiction consult service.

Conclusion: MAUD initiation during alcohol withdrawal hospitalizations was low and varied by patient factors and hospital sites. Factors driving this variation can inform interventions to address MAUD underutilization.

背景:酒精戒断住院治疗为开始使用酒精使用障碍(MAUD)药物提供了未满足的机会。目的:探讨住院期间与MAUD发生相关的患者和医院因素。方法:利用电子健康记录和2022 - 2024年的药房数据,对大型卫生系统中酒精戒断住院患者进行回顾性队列研究。结果是MAUD起始定义为住院患者注射纳曲酮或门诊患者口服纳曲酮、阿坎普罗酸、双硫仑、托吡酯或巴氯芬。我们排除了在前90天内填写MAUD的患者。我们使用了一个多变量线性模型,其中社会经济、临床和住院因素作为固定效应,个体患者和医院地点作为随机效应来解释聚类。结果:在12家医院的5993例酒精戒断住院患者中,19.8%(范围:5.1%- 43.2%)开始了MAUD。口服纳曲酮是最常见的MAUD,而托吡酯是最不常见的(分别占66.9%和1.2%)。年龄≥65岁(调整后的绝对差值为-6.89个百分点[pp] vs.年龄为18-29岁;95%可信区间[CI] -12.20, -1.58)和无肝硬化且肝酶低于200 U/L (-3.46 pp vs.肝酶≤200 U/L; 95% CI: -6.87, -0.01)的患者发生MAUD的可能性较小。四家医院启动MAUD的比率明显较低,两家的比率较高,其中包括唯一一家提供成瘾咨询服务的医院。结论:酒精戒断住院期间MAUD起始率较低,且因患者因素和医院地点而异。导致这种差异的因素可以为干预措施提供信息,以解决MAUD利用不足的问题。
{"title":"Variation in initiation of medications for alcohol use disorder during alcohol withdrawal hospitalizations in a large health system: A retrospective cohort study.","authors":"Eden Y Bernstein, Jacob A Lebin, Jason Hoppe, Izzie Clinton, R Mark Gritz, Gina R Kruse, E Jennifer Edelman","doi":"10.1002/jhm.70201","DOIUrl":"https://doi.org/10.1002/jhm.70201","url":null,"abstract":"<p><strong>Background: </strong>Alcohol withdrawal hospitalizations present unmet opportunities to initiate medications for alcohol use disorder (MAUD).</p><p><strong>Objective: </strong>To examine patient and hospital factors associated with MAUD initiation during hospitalizations.</p><p><strong>Methods: </strong>We conducted a retrospective cohort study of alcohol withdrawal hospitalizations in a large health system using electronic health record and pharmacy data from 2022 to 2024. The outcome was MAUD initiation defined as inpatient administration of injectable naltrexone or prescriptions for outpatient oral naltrexone, acamprosate, disulfiram, topiramate, or baclofen. We excluded patients who filled MAUD in the prior 90 days. We used a multivariable linear model with socioeconomic, clinical, and hospitalization factors as fixed effects and individual patients and hospital sites as random effects to account for clustering.</p><p><strong>Results: </strong>Among 5993 alcohol withdrawal hospitalizations across 12 hospitals, 19.8% (range: 5.1%- 43.2%) initiated MAUD. Oral naltrexone was the most common MAUD initiated, while topiramate was the least common (66.9% and 1.2% of MAUD initiated, respectively). Patients less likely to initiate MAUD were age ≥ 65 years (absolute adjusted difference -6.89 percentage points [pp] vs. age 18-29; 95% confidence interval [CI] -12.20, -1.58) and those without cirrhosis and liver enzymes >200 U/L (-3.46 pp vs. liver enzymes ≤ 200 U/L; 95% CI: -6.87, -0.01). Four hospitals initiated MAUD at significantly lower rates, and two at higher rates including the only hospital with an addiction consult service.</p><p><strong>Conclusion: </strong>MAUD initiation during alcohol withdrawal hospitalizations was low and varied by patient factors and hospital sites. Factors driving this variation can inform interventions to address MAUD underutilization.</p>","PeriodicalId":94084,"journal":{"name":"Journal of hospital medicine","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2025-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145253846","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bent not broken. 弯而不断。
IF 2.3 Pub Date : 2025-10-07 DOI: 10.1002/jhm.70200
Rogie Gabrielle
{"title":"Bent not broken.","authors":"Rogie Gabrielle","doi":"10.1002/jhm.70200","DOIUrl":"https://doi.org/10.1002/jhm.70200","url":null,"abstract":"","PeriodicalId":94084,"journal":{"name":"Journal of hospital medicine","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2025-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145245994","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Approach to hyperleukocytosis and leukostasis- inpatient management strategies. 白细胞增多症和白细胞停滞症的治疗策略。
IF 2.3 Pub Date : 2025-10-07 DOI: 10.1002/jhm.70199
Maun R Baral, Sambhawana Bhandari

Hyperleukocytosis is defined as a white blood cell count exceeding 100,000/µL and is a critical manifestation of acute and chronic leukemia. It can lead to life-threatening complications such as leukostasis, disseminated intravascular coagulation, and tumor lysis syndrome. Leukostasis results from microvascular obstruction by leukemic blasts, causing multisystemic manifestations. Leukostasis is primarily a clinical diagnosis requiring prompt recognition and intervention. Supportive care includes intravenous hydration, uric acid-lowering agents, and cautious blood transfusions to prevent worsening hyperviscosity. Hydroxyurea and cytarabine are used as cytoreductive agents until a definitive diagnosis and management are started. The role of leukapheresis is controversial, and practice patterns differ between clinicians and institutions.

白细胞增多症被定义为白细胞计数超过100,000/µL,是急性和慢性白血病的重要表现。它可导致危及生命的并发症,如白细胞淤积、弥散性血管内凝血和肿瘤溶解综合征。白血病细胞引起微血管阻塞,引起多系统表现。白细胞淤积主要是一种临床诊断,需要及时识别和干预。支持性治疗包括静脉补水、降尿酸药物和谨慎输血以防止高粘度恶化。羟基脲和阿糖胞苷被用作细胞还原剂,直到明确的诊断和治疗开始。白细胞分离的作用是有争议的,临床医生和机构之间的实践模式不同。
{"title":"Approach to hyperleukocytosis and leukostasis- inpatient management strategies.","authors":"Maun R Baral, Sambhawana Bhandari","doi":"10.1002/jhm.70199","DOIUrl":"https://doi.org/10.1002/jhm.70199","url":null,"abstract":"<p><p>Hyperleukocytosis is defined as a white blood cell count exceeding 100,000/µL and is a critical manifestation of acute and chronic leukemia. It can lead to life-threatening complications such as leukostasis, disseminated intravascular coagulation, and tumor lysis syndrome. Leukostasis results from microvascular obstruction by leukemic blasts, causing multisystemic manifestations. Leukostasis is primarily a clinical diagnosis requiring prompt recognition and intervention. Supportive care includes intravenous hydration, uric acid-lowering agents, and cautious blood transfusions to prevent worsening hyperviscosity. Hydroxyurea and cytarabine are used as cytoreductive agents until a definitive diagnosis and management are started. The role of leukapheresis is controversial, and practice patterns differ between clinicians and institutions.</p>","PeriodicalId":94084,"journal":{"name":"Journal of hospital medicine","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2025-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145245963","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Large language model-based identification of venous thromboembolism diagnostic delays. 基于大语言模型的静脉血栓栓塞诊断延迟识别。
IF 2.3 Pub Date : 2025-10-07 DOI: 10.1002/jhm.70194
Verity Schaye, Daniel J Sartori, Lexi Signoriello, Kiran Malhotra, Benedict Guzman, Bijal Rajput, Ilan Reinstein, Jesse Burk-Rafel

Background: Delayed diagnosis of venous thromboembolism (VTE) is prevalent among hospitalized patients, yet case identification is challenging and feedback limited.

Objective: To develop a large language model (LLM)-based electronic-trigger to identify VTE diagnostic delays.

Methods: All admissions to internal medicine (IM) residents at NYU Langone Health between January 2022 and December 2023 (n = 20,843) were included. Using an open-source LLM, prompts were validated to detect (1) residents considering VTE in admission notes and (2) VTE confirmation in five types of imaging reports (n = 100 for each prompt validation set). The validated prompts were applied to determine discordance between admission note differential omitting VTE and imaging report confirming VTE. Two hospitalists reviewed discordant cases using a validated tool to identify diagnostic delays. Hospitalizations were labeled as diagnostic delays, in-hospital complication, or false-positive. Based on in-hospital complication and false-positive patterns, exclusion criteria were implemented. Positive predictive value (PPV) and negative predictive value (NPV) were calculated.

Results: The LLM prompts correctly classified admission notes and VTE imaging studies with high accuracy (range 98%-100%, n = 699 VTE cases identified). Of the 137 diagnostic delays the LLM-based electronic-trigger identified, 31 were true-positives, 60 in-hospital complications, and 46 false-positives. 4.4% of all VTE hospitalizations had a diagnostic delay. With the exclusion criteria, the PPV was 48% (95% confidence interval [CI], 35%-62%) and NPV was 95% (95% CI, 87%-98%).

Conclusions: We developed the first LLM-based electronic-trigger to identify VTE diagnostic delays, with higher performance than existing non-LLM electronic-triggers. LLM-based approaches can facilitate diagnostic performance feedback and are scalable to other conditions and institutions.

背景:静脉血栓栓塞(VTE)的延迟诊断在住院患者中很普遍,但病例识别具有挑战性,反馈有限。目的:开发一种基于大语言模型(LLM)的VTE诊断延迟的电子触发器。方法:纳入2022年1月至2023年12月期间NYU Langone Health所有住院内科(IM)住院医师(n = 20,843)。使用开源LLM,对提示进行验证,以检测(1)住院医师在入院记录中考虑VTE,(2)在五种类型的成像报告中确认VTE(每个提示验证集n = 100)。应用经过验证的提示来确定忽略VTE的入院记录差异与确认VTE的影像学报告之间的不一致。两名医院医生使用经过验证的工具审查了不一致的病例,以确定诊断延误。住院治疗被标记为诊断延误、院内并发症或假阳性。根据院内并发症和假阳性模式,实施排除标准。计算阳性预测值(PPV)和阴性预测值(NPV)。结果:LLM提示正确分类的入院记录和VTE成像研究具有很高的准确性(范围98%-100%,n = 699例VTE确诊病例)。在基于llm的电子触发器识别的137例诊断延迟中,31例为真阳性,60例为院内并发症,46例为假阳性。所有静脉血栓栓塞住院患者中有4.4%的诊断延迟。根据排除标准,PPV为48%(95%可信区间[CI], 35%-62%), NPV为95% (95% CI, 87%-98%)。结论:我们开发了第一个基于llm的电子触发器来识别静脉血栓栓塞诊断延迟,其性能比现有的非llm电子触发器更高。基于法学硕士的方法可以促进诊断性能反馈,并可扩展到其他条件和机构。
{"title":"Large language model-based identification of venous thromboembolism diagnostic delays.","authors":"Verity Schaye, Daniel J Sartori, Lexi Signoriello, Kiran Malhotra, Benedict Guzman, Bijal Rajput, Ilan Reinstein, Jesse Burk-Rafel","doi":"10.1002/jhm.70194","DOIUrl":"https://doi.org/10.1002/jhm.70194","url":null,"abstract":"<p><strong>Background: </strong>Delayed diagnosis of venous thromboembolism (VTE) is prevalent among hospitalized patients, yet case identification is challenging and feedback limited.</p><p><strong>Objective: </strong>To develop a large language model (LLM)-based electronic-trigger to identify VTE diagnostic delays.</p><p><strong>Methods: </strong>All admissions to internal medicine (IM) residents at NYU Langone Health between January 2022 and December 2023 (n = 20,843) were included. Using an open-source LLM, prompts were validated to detect (1) residents considering VTE in admission notes and (2) VTE confirmation in five types of imaging reports (n = 100 for each prompt validation set). The validated prompts were applied to determine discordance between admission note differential omitting VTE and imaging report confirming VTE. Two hospitalists reviewed discordant cases using a validated tool to identify diagnostic delays. Hospitalizations were labeled as diagnostic delays, in-hospital complication, or false-positive. Based on in-hospital complication and false-positive patterns, exclusion criteria were implemented. Positive predictive value (PPV) and negative predictive value (NPV) were calculated.</p><p><strong>Results: </strong>The LLM prompts correctly classified admission notes and VTE imaging studies with high accuracy (range 98%-100%, n = 699 VTE cases identified). Of the 137 diagnostic delays the LLM-based electronic-trigger identified, 31 were true-positives, 60 in-hospital complications, and 46 false-positives. 4.4% of all VTE hospitalizations had a diagnostic delay. With the exclusion criteria, the PPV was 48% (95% confidence interval [CI], 35%-62%) and NPV was 95% (95% CI, 87%-98%).</p><p><strong>Conclusions: </strong>We developed the first LLM-based electronic-trigger to identify VTE diagnostic delays, with higher performance than existing non-LLM electronic-triggers. LLM-based approaches can facilitate diagnostic performance feedback and are scalable to other conditions and institutions.</p>","PeriodicalId":94084,"journal":{"name":"Journal of hospital medicine","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2025-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145246044","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical guidelines highlight for the hospitalist: Management of cyclic vomiting syndrome in children. 临床指南强调医院医生:管理循环呕吐综合征的儿童。
IF 2.3 Pub Date : 2025-10-07 DOI: 10.1002/jhm.70190
Yamileth N Hernandez, Hannah M Gardner
{"title":"Clinical guidelines highlight for the hospitalist: Management of cyclic vomiting syndrome in children.","authors":"Yamileth N Hernandez, Hannah M Gardner","doi":"10.1002/jhm.70190","DOIUrl":"https://doi.org/10.1002/jhm.70190","url":null,"abstract":"","PeriodicalId":94084,"journal":{"name":"Journal of hospital medicine","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2025-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145240583","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Securing benefits of crisis-driven innovations. 确保危机驱动型创新的收益。
IF 2.3 Pub Date : 2025-10-02 DOI: 10.1002/jhm.70180
Marina Dantas, Jessica L Markham
{"title":"Securing benefits of crisis-driven innovations.","authors":"Marina Dantas, Jessica L Markham","doi":"10.1002/jhm.70180","DOIUrl":"10.1002/jhm.70180","url":null,"abstract":"","PeriodicalId":94084,"journal":{"name":"Journal of hospital medicine","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2025-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12631963/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145208830","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A rhyme and reason for swelling. 肿胀的韵律和原因。
IF 2.3 Pub Date : 2025-10-02 DOI: 10.1002/jhm.70184
Aditya Kesari, Sanjay A Patel, Anand D Jagannath, Michelle Fleshner
{"title":"A rhyme and reason for swelling.","authors":"Aditya Kesari, Sanjay A Patel, Anand D Jagannath, Michelle Fleshner","doi":"10.1002/jhm.70184","DOIUrl":"https://doi.org/10.1002/jhm.70184","url":null,"abstract":"","PeriodicalId":94084,"journal":{"name":"Journal of hospital medicine","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2025-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145214860","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Methodological progress note: Logic models. 方法进展说明:逻辑模型。
IF 2.3 Pub Date : 2025-10-02 DOI: 10.1002/jhm.70181
Molly J Horstman, Kyler M Godwin

Logic models are an accessible tool to organize the planning, management, and evaluation of programs across healthcare disciplines. This methodological progress note describes the five standard components of a logic model (Inputs, Activities, Outputs, Outcomes, and Impact) and provides guidance for developing a logic model. Logic models offer a visual representation of the work and theory of a program and should be created with input from all interested parties. Logic models are living tools that need to be revised as programs evolve and new information becomes available.

逻辑模型是一种可访问的工具,用于组织跨医疗保健学科的计划、管理和评估。本方学进度说明描述了逻辑模型的五个标准组成部分(输入、活动、输出、结果和影响),并为开发逻辑模型提供了指导。逻辑模型提供了程序的工作和理论的可视化表示,应该使用所有相关方的输入来创建。逻辑模型是活的工具,需要随着程序的发展和新信息的出现而进行修订。
{"title":"Methodological progress note: Logic models.","authors":"Molly J Horstman, Kyler M Godwin","doi":"10.1002/jhm.70181","DOIUrl":"https://doi.org/10.1002/jhm.70181","url":null,"abstract":"<p><p>Logic models are an accessible tool to organize the planning, management, and evaluation of programs across healthcare disciplines. This methodological progress note describes the five standard components of a logic model (Inputs, Activities, Outputs, Outcomes, and Impact) and provides guidance for developing a logic model. Logic models offer a visual representation of the work and theory of a program and should be created with input from all interested parties. Logic models are living tools that need to be revised as programs evolve and new information becomes available.</p>","PeriodicalId":94084,"journal":{"name":"Journal of hospital medicine","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2025-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145208694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quality assessment of artificial intelligence-generated versus human-written hospital summaries evaluating detail, usefulness, and continuity of care. 人工智能生成的与人类撰写的医院摘要的质量评估,评估细节、有用性和护理的连续性。
IF 2.3 Pub Date : 2025-09-30 DOI: 10.1002/jhm.70163
Douglas Challener, Shant Ayanian, Alexander Ryu, John O'Horo, Heather Heaton

Background: Hospital discharge summaries are critical for ensuring continuity of care, but their quality often varies. Large language models (LLMs) have the potential to standardize and enhance the efficiency of this documentation process.

Objectives: To evaluate the quality of hospital discharge summaries created by an LLM-based hospital course drafting tool created by Epic Systems compared with human-written summaries.

Methods: Retrospective study at a single tertiary-care institution in 2024. The cohort included 100 adult hospitalizations lasting >72 hours across medical and surgical dismissing services. No interventions were performed. Summaries (LLM-generated vs human-written) were independently reviewed using a standardized rubric covering nine domains (e.g., comprehensiveness, clarity, relevance). Scores were normalized and compared. Readability was assessed using Flesch Reading Ease.

Results: LLM-generated summaries outperformed human-written summaries across all criteria (p < .05), with the greatest difference observed in comprehensiveness (LLM median 0.62 vs. human -0.23). Human-written summaries from surgical services scored lower than those from medical services, but LLM performance was consistent across both. Human summaries had higher Flesch Reading Ease scores (33.11 vs. 26.2; p < .05), reflecting simpler language.

Conclusions: LLM-generated summaries demonstrated superior quality, consistency, and clinical utility compared with human-written summaries, highlighting their potential to improve documentation efficiency and standardization.

背景:出院摘要对确保护理的连续性至关重要,但其质量往往参差不齐。大型语言模型(llm)具有标准化和提高文档流程效率的潜力。目的:评估由Epic Systems创建的基于法学硕士的医院课程起草工具创建的出院摘要的质量,并与人工撰写的摘要进行比较。方法:于2024年在一家三级医疗机构进行回顾性研究。该队列包括100名在医疗和外科出院服务中住院的成年人,持续时间为bbb72小时。未进行干预。摘要(法学硕士生成的与人工编写的)使用涵盖九个领域(例如,全面性,清晰度,相关性)的标准化标题进行独立审查。将得分归一化并进行比较。使用Flesch Reading Ease评估可读性。结果:llm生成的摘要在所有标准上都优于人类编写的摘要(p)。结论:与人类编写的摘要相比,llm生成的摘要表现出更高的质量、一致性和临床实用性,突出了它们在提高文档效率和标准化方面的潜力。
{"title":"Quality assessment of artificial intelligence-generated versus human-written hospital summaries evaluating detail, usefulness, and continuity of care.","authors":"Douglas Challener, Shant Ayanian, Alexander Ryu, John O'Horo, Heather Heaton","doi":"10.1002/jhm.70163","DOIUrl":"https://doi.org/10.1002/jhm.70163","url":null,"abstract":"<p><strong>Background: </strong>Hospital discharge summaries are critical for ensuring continuity of care, but their quality often varies. Large language models (LLMs) have the potential to standardize and enhance the efficiency of this documentation process.</p><p><strong>Objectives: </strong>To evaluate the quality of hospital discharge summaries created by an LLM-based hospital course drafting tool created by Epic Systems compared with human-written summaries.</p><p><strong>Methods: </strong>Retrospective study at a single tertiary-care institution in 2024. The cohort included 100 adult hospitalizations lasting >72 hours across medical and surgical dismissing services. No interventions were performed. Summaries (LLM-generated vs human-written) were independently reviewed using a standardized rubric covering nine domains (e.g., comprehensiveness, clarity, relevance). Scores were normalized and compared. Readability was assessed using Flesch Reading Ease.</p><p><strong>Results: </strong>LLM-generated summaries outperformed human-written summaries across all criteria (p < .05), with the greatest difference observed in comprehensiveness (LLM median 0.62 vs. human -0.23). Human-written summaries from surgical services scored lower than those from medical services, but LLM performance was consistent across both. Human summaries had higher Flesch Reading Ease scores (33.11 vs. 26.2; p < .05), reflecting simpler language.</p><p><strong>Conclusions: </strong>LLM-generated summaries demonstrated superior quality, consistency, and clinical utility compared with human-written summaries, highlighting their potential to improve documentation efficiency and standardization.</p>","PeriodicalId":94084,"journal":{"name":"Journal of hospital medicine","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145202519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of hospital medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1